fda tirzepatide shortage list GLP-1 Drugs: Removes Lilly's Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Drug Shortages Infographic | FDA
Description
April 24-27, 2025

When using this product marked drowsiness may occur excitability may occur, especially in children alcohol, sedatives and tranquilizers may increase drowsiness do not drive, operate machinery or engage in activities requiring mental alertness avoid alcoholic drinks
41 However, these changes in autonomic tone are heterogeneous
How the FAA Reviews Weight Loss Medications Disclosure Requirements Pilots must report prescription medications and visits to medical professionals to their Aviation Medical Examiner (AME)
